Clinical Studies with Paclitaxel - Eluting Stent Systems

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|36|4025-4036

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.36, 2010-12, pp. : 4025-4036

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Studies with Sirolimus, Zotarolimus, Everolimus and Biolimus A9 Drug- Eluting Stent Systems

By  

Current Pharmaceutical Design, Vol. 16, Iss. 36, 2010-12 ,pp. : 4012-4024

Bentham Science Publishers

Access to resources Recommend Favorite

Paclitaxel-eluting stent safe, effective against restenosis

By  

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Paclitaxel-eluting stent superior to VBT in restenosis

By  

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Paclitaxel: False aneurysm following placement of drug-eluting stent: case report

By  

Reactions Weekly, Vol. 1, Iss. 1213, 2008-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite